FDA approves treatment for patients with a type of inflammatory arthritis

The FDA is approving Cimzia (certolizumab pegol) injection for treatment of adults with a certain type of inflammatory arthritis. This is the first time that the FDA has approved a treatment for non-radiographic axial spondyloarthritis (nr-axSpA). nr-axSpA is a type of inflammatory arthritis that causes inflammation in the spine and other symptoms

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm634671.htm

Source: Food and Drug Administration - March 28, 2019 Category: American Health Source Type: news

More News: American Health | Arthritis | Food and Drug Administration (FDA) | Radiography | Rheumatology